Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v1-EN
Language French English
Date Updated 2024-04-02 2024-01-30
Drug Identification Number 02526875 02526875
Brand name SANDOZ AMBRISENTAN TABLETS SANDOZ AMBRISENTAN TABLETS
Common or Proper name AMBRISENTAN TABLETS AMBRISENTAN TABLETS
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients AMBRISENTAN AMBRISENTAN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30FCT 30FCT
ATC code C02KX C02KX
ATC description OTHER ANTIHYPERTENSIVES OTHER ANTIHYPERTENSIVES
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2024-01-30 2024-01-30
Estimated end date 2024-04-12 2024-02-23
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments